Treatment Regimens for Mifegyne and Cytotec

Comparison of the Effectiveness of Abortive Measures From the Administration of Mifegyne and Cytotec at One and Two Visits

Status

UNKNOWN

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00920465

Enrollment

200

Registered

2009-06-15

Start date

2009-06-30

Completion date

2011-12-31

Last updated

2011-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medical Abortion

Brief summary

The purpose of this study is to test two regimens of mifegyne and cytotec for medical abortion. The investigators hypothesize that administration of both medications during one hospital visit will not compromise effectiveness.

Interventions

DRUGmifegyne and cytotec

One day dosage versus two days dosage

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 50 Years

Healthy volunteers

Inclusion criteria

* above age 18, * for whom Mifegyne and cytotec are indicated.

Exclusion criteria

* inflammation of oral cavity.

Design outcomes

Primary

Measure	Time frame
percentage of complete abortion	one month

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026